Screener
10x Genomics, Inc. TXG Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from 10x Genomics, Inc.’s reported figures.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
FAQ
- What is 10x Genomics, Inc.'s free cash flow?
- 10x Genomics, Inc. (TXG) reported free cash flow of $15.39M in Q2 2026.
- How has 10x Genomics, Inc.'s free cash flow changed year-over-year?
- 10x Genomics, Inc.'s free cash flow decreased by 4.6% year-over-year, from $16.13M to $15.39M.
- What is the long-term trend for 10x Genomics, Inc.'s free cash flow?
- Over 2 years (2021 to 2025), 10x Genomics, Inc.'s free cash flow has grown at a 3.0% compound annual growth rate (CAGR), from -$122.65M to $130.12M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about 10x Genomics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude